Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 481-670-5 | CAS number: 848301-66-6
Toxicological Summary
Administrative data
Workers - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Workers - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
Workers - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- no hazard identified
Additional information - workers
The test item is not hazardous for human health with respect to skin irritation, eye irritation, acute toxicity (lethality or specific target organ toxicity following a single exposure), sensitisation, specific target organ toxicity following repeated exposures, reproductive toxicity, developmental toxicity, carcinogenicity and genetic toxicity.
The critical health effects are aspiration hazard (potential lung damage following accidental swallowing) and potential skin dryness or cracking following repeated dermal exposures. It is not possible to determine quantitative dose descriptors for these effects.
In the absence of adverse effects in acute and long-term systemic and reproductive studies it is not possible to determine DNEL values for systemic effects and risk characterisation is not necessary.
Qualitative risk characterisation is required based on the aspiration hazard and potential skin dryness and cracking.General Population - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
General Population - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
General Population - Hazard via oral route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
General Population - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- no hazard identified
Additional information - General Population
The substance is not hazardous for human health with respect to skin irritation, eye irritation, acute toxicity (lethality or specific target organ toxicity following a single exposure), sensitisation, specific target organ toxicity following repeated exposures, reproductive toxicity, developmental toxicity, carcinogenicity and genetic toxicity.
The critical health effects are aspiration hazard (potential lung damage following accidental swallowing) and potential skin dryness or cracking following repeated dermal exposures. It is not possible to determine quantitative dose descriptors for these effects.
In the absence of adverse effects in acute and long-term systemic and reproductive studies it is not possible to determine DNEL values for systemic effects and risk characterisation is not necessary.
Qualitative risk characterisation is required based on the aspiration hazard and potential skin dryness and cracking.Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
